By Karen Roman Agendia, Inc. said its gene expression profiling test MammaPrint can predict extended endocrine therapy ...

Researchers at Osaka University identified a degradation factor for SREBP1 as essential for maintaining the balance of ...

"This study underscores the impact of dd-cfDNA as a critical biomarker for early AMR detection, providing healthcare teams with timely data enabling them to initiate treatments sooner," said Dr. Aylin ...

A secondary analysis of the randomized controlled trial, IDEAL, confirms results from NSABP B-42 demonstrating MammaPrint is ...

If you’ve ever felt a twinge of guilt during a shopping spree, let this be the season you let it go. This year, as you dive into the holiday shopping frenzy, remember: shopping is more than a habit—it ...

On Nov. 15 the Buffalo State Communications Department held its annual Research and Creativity Forum. Held every year during ...